Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge

By Pal S.   Barnhart K.M.   Wei Q.   Abai A.M.   Peterson E.M.   de la Maza L.M.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 459-465

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection

By Hua S.   Parnell M.   Caldwell H.D.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1023-1032

Elsevier

Access to resources Recommend Favorite

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

By Whittum-Hudson J.A.   Rudy D.   Gerard H.   Vora G.   Davis E.   Haller P.K.   Prattis S.M.   Hudson A.P.   Saltzman W.M.   Stuart E.S.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 4061-4071

Elsevier

Access to resources Recommend Favorite

Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge

By Pal S.   Theodor I.   Peterson E.M.   de la Maza L.M.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 575-582

Elsevier

Access to resources Recommend Favorite

Adverse impact of infections on antibody responses to measles vaccination

By Migasena S.   Simasathien S.   Samakoses R.   Pitisuttitham P.   Heath J.   Bellini W.   Bennett J.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 647-652

Elsevier

Access to resources Recommend Favorite